Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Tesamorelin is the only one with current FDA approval and Phase III trial data showing visceral fat reduction
Injectable peptides marketed for knees are largely supported by animal data rather than knee patient trials
Clinical studies show that approximately 50% to 70% of lost weight is regained within a year of discontinuation, which underscores the challenge of achieving lasting results
Gould NS, et al
By blocking NNMT, 5-Amino-1MQ helps restore cellular balance and metabolic output
Related products PEG MGF 2 mg $50.00 GDF-8 1 mg $20.00
US$ 25.46
US$ 20.33
:max_bytes(150000):strip_icc()/VWH-GettyImages-2059065209-7ab09bdd0be8409493ace4364fccf792.jpg)
US$ 22.50
